Key facts
- It has raised $500K; the latest was Seed Round ($500K) in Mar 2025.
- Notable investors include Alphabet, Amazon Web Services, Avatia Pharmaceutical, FNODE Venture, M2M Capital (HK) — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for GenPharmaChain
- ·The full record, as it builds
Funding rounds
No funding rounds for GenPharmaChain are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GenPharmaChain
Developer of blockchain and decentralized technology designed to refine artificial intelligence-driven pharmaceutical models. The company's technology offers a production and distribution model of generic drugs, ensuring transparency, traceability, lower costs, and greater accessibility, enabling scientists to integrate modules to simulate drug interactions, facilitating biomedical research.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2025
- Website
- genpharmchain.com/
- Ownership
- Privately Held (backing)
GenPharmaChain doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GenPharmaChain shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GenPharmaChain in its N-PORT filings yet. We sweep new filings monthly.